BOK Financial’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
Other funds holding ANIK
TI
BOK Financial's ANIK Position: Q2 2022 in Review
BOK Financial sold out of Anika Therapeutics (ANIK) in Q2 2022, closing a stake of 8,692 shares — an estimated $218K sold.
BOK Financial first reported a position in ANIK in Q4 2016 and held it in 21 quarters. The position peaked at $640K in Q3 2017. 125 funds tracked by Wall St. Rank hold ANIK as of Q2 2022.
- BOK Financial reported no remaining Anika Therapeutics position as of Q2 2022 after selling out during the quarter.
- BOK Financial sold 8,692 Anika Therapeutics shares in Q2 2022, an estimated $218K.
- BOK Financial first reported a position in Anika Therapeutics in Q4 2016 and held it in 21 quarters.
- BOK Financial's Anika Therapeutics position peaked at $640K in Q3 2017.
- 125 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2022.
Based on BOK Financial's 13F filing for Q2 2022, filed 11 Aug 2022.